Higher "normal" glycated hemoglobin levels were associated with increased risk for diabetes, CVD, stroke, and mortality in adults: Commentary

Annals of Internal Medicine

Volumn 153, Issue 2, 2010, Pages

  Smith, Steven A ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

AGING; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; GLYCATION; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MORTALITY; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; SMOKING; STROKE;

EID: 77957197221     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-153-2-201007200-02013     Document Type: Note

References (5)

1. Selvin E, Zhu H, Brancati FL. Elevated A1c in adults without a history of diabetes in the US. Diabetes Care. 2009;32:828-33.
2. Fonseca V, Inzucchi SE, Ferrannini E. Redefining the diagnosis of diabetes using glycated hemoglobin [Editorial]. Diabetes Care. 2009;32: 1344-5.
3. Bloomgarden ZT. Cardiovascular disease, neuropathy, and retinopathy. Diabetes Care. 2009;32:e64-8.
4. Little RR. Glycated hemoglobin standardization - National Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab Med. 2003;41:1191-8.
5. Holmes EW, Erşahin C, Augustine GJ, et al. Analytic bias among certified methods for the measurement of hemoglobin A1c: a cause for concern? Am J Clin Pathol. 2008;129:540-7.